Neurosteroids and their function;Neurosteroidy a jejich význam

Casopis Lekaru Ceskych

Volumn 146, Issue 3, 2007, Pages 223-226

  Bicikoya M ^a,b   Hampl, R ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b NONE   (Czech Republic)

Author keywords

Allopregnanolone; Enzymes; GABAA; NMDA; Receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CALCIUM CHANNEL; ELTANOLONE; PRASTERONE; STEROID;

CENTRAL NERVOUS SYSTEM; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

CALCIUM CHANNELS; CENTRAL NERVOUS SYSTEM; DEHYDROEPIANDROSTERONE; GABA MODULATORS; HUMANS; PREGNANOLONE; RECEPTORS, GABA-A; STEROIDS;

EID: 33947529729     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Baulieu, E. E.: In: Fuxe, K., Gustafson, J. A., Wetterberg, L. (eds.) Steroid Hormone Regulation of the Brain. Oxford, Wenner-Green Center International Symposium Series, Pergamon Press, 1981, 34, s. 3-14.
2. Brown, R. C., Cascio, C., Papadopoulos, V.: Pathways of neurosteroid biosynthesis in cell lines from human brain: Regulation of dehydroepiandrosterone formation by oxidative stress and b-amyloid peptide. J. Neurochem. 2000, 74, s. 847-859.
3. Compagnone, N. A., Mellon, S. H,: Neurosteroids: Biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 2000, 21, s. 1-56.
4. Purdy, R. H., Morrow, A. L., Moore, S. H. Jr., Paul, S. M.: Stress-induced elevation of g- aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA, 1991, 88, s. 4553-4557.
5. A receptor function after acute stress. Neuroendocrinology, 1996, 63, s. 166-172.
6. Dong, E., Matsumoto, K., Uzunova, V. et al.: Brain 5α-dihydroprogesterone amd allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. USA, 2001, 98, s. 2849-2854.
7. Reddy, D. S.: Pharmacology of endogenous neuroactive steroids. Crit. Rev. Neurobiol., 2003, 15, s. 197-234.
8. Bičíková, M., Dibbelt, L., Hill, M. et al.: Allopregnanolone in women with premenstrual syndrome. Horm. Metab. Res., 1998, 30, s. 227-230.
9. Monteleone, S., Luisi, S., Tonetti, A. et al.: Allopregnanolone concentrations and premenstrual syndrome. E. J. Endocrinol., 2000, 142, s. 269-273.
10. Bičíková, M., Tallová, J., Hill, M. et al.: Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder. Neurochem. Res., 2000, 251, s. 623-627.
11. van Broekhoven, F., Verkes, R. J.: Neurosteroids in depression: a review. Psychopharmacology (Berlin), 2003, 165, s. 97-110.
12. Stárka, L., Bičíkova, M., Hill, M. et al.: Estrogeny a psychické poruchy u žen. Psychiatrie, 2003, 7, s. 178-183.
13. Barbosa, A. D., Morato, G. S.: Effect of epipregnanolone and pregnenolone sulfate on chronic tolerance to ethanol. Pharmacol. Biochem. Behav., 2000, 67, s. 459-464.
14. Brown, R. C., Cascio, C., Papadopoulos, V.: Pathways of neurosteroid biosynthesis in cell lines from human brain:regulation of dehydropiandrosterone formation by oxidative stress and beta-amyloid peptide. J. Neurochem., 2000, 74, s. 847-859.
15. Kalimi, M., Regelson, W.: In: Dehydroepiandrosterone (DHEA), biochemical, physiological and clinical aspects. New York and Berlin, Walter de Gruyter, 2000.
16. Hampl, R., Stárke, L.: Dehydroepiandrosteron, hormon mládí" ve světle současných poznatků. Čas. Lék. čes., 1998, 137, s. 8-12.
17. Kalimi, M., Shafagoj, Y., Loria, R. M. et al.: Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell Biochem., 1994, 131, s. 99-104.
18. Wolkowitz, O. W., Reus, V. I.: Neuropsychiatric effects of dehydroepiandrosterone (DHEA). In: Kalimi, M., Regelson, W. (eds.) Dehydroepiandrosterone (DHEA), biochemical, physiological and clinical aspects.New York and Berlin: Walter de Gruyter, 2000, s. 270-298.
19. Wolf, O. T., Kirschbaum, C.: DHEA replacement and cognition in healthy elderly humans. A summary of results from placebo controlled experiments. In: DHEA and the brain. Ed R Morfin. London and New York, Taylor and Francis, 2002, s. 187-198.
20. Morfin, R., Stárka, L: Neurosteroid 7-Hydroxylation products in the brain. Int. Rev. Neurobiol., 2001, 46, s. 79-95.
21. Akwa, Y., Sananes, N., Gouezou, M. et al.: Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J. Cell Biol., 1993, 121, s. 135-143.
22. Trincal, M., Loeper, J., Pompon, D. et al.: DHEA metabolism in the brain: production and effects of the 7α-hydroxylated derivative. In: DHEA and the brain, Morfin, R. (ed.). London and New York, Taylor and Francis, 2002, s. 117-128.
23. Kim, S. B., Hill, M., Kwak, Y. T. et al.: Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnosis. J. Clin. Endocrinol. Metab., 2003, 88, s. 5199-5206.
24. Bičíková, M., Ripová, D., Hill, M. et al.: Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amin-thiols as discriminatory tools of Alzheimer's disease and vascular dementia. Clin. Chem. Lab. Med., 2004, 42, s. 518-524.
25. Dudas, B., Hanin, I., Rose, M., Wulfert, E.: Protection against neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone. A novel neurosteroid. Neurobiol. Dis., 2004, 15, s. 262-268.
26. Brinton, R. D., Wang, J. M.: Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr. Alzeimer Res., 2006, 3, s. 185-190.